Magle Chemoswed Holding AB (publ)

SSE:MAGLE.ST

27.6 (SEK) • At close February 19, 2024
Bedrijfsnaam Magle Chemoswed Holding AB (publ)
Symbool MAGLE.ST
Munteenheid SEK
Prijs 27.6
Beurswaarde 298,080,000
Dividendpercentage 1.08%
52-weken bereik 21.4 - 38
Industrie Biotechnology
Sector Healthcare
CEO Mr. Hans Henrik Lidgard
Website https://www.maglechemoswed.com

An error occurred while fetching data.

Over Magle Chemoswed Holding AB (publ)

Magle Chemoswed Holding AB (publ) engages in the research, development, and manufacturing in the areas of pharmaceutical chemistry and pharmaceutical technology in Sweden. The company focuses on the process development and manufacture of active pharmaceutical ingredients (API); and research, development, and production of products in the areas of wound care

Vergelijkbare Aandelen

AcouSort AB (publ) logo

AcouSort AB (publ)

ACOU.ST

13.2 SEK

Clinical Laserthermia Systems AB (publ) logo

Clinical Laserthermia Systems AB (publ)

CLS-B.ST

0.102 SEK

ProstaLund AB (publ) logo

ProstaLund AB (publ)

PLUN.ST

1.575 SEK

Active Biotech AB (publ) logo

Active Biotech AB (publ)

ACTI.ST

0.685 SEK

aXichem AB logo

aXichem AB

AXIC-A.ST

1.7 SEK

SenzaGen AB logo

SenzaGen AB

SENZA.ST

6.7 SEK

Corline Biomedical AB logo

Corline Biomedical AB

CLBIO.ST

13.8 SEK

Financiële Gegevens

Cijfers zijn in miljoenen (SEK)

Cijfers zijn in miljoenen (SEK)